Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience
Applied Biosafety · 01.09.2021 · 26 (S1) · S-10-S-15
DOI: 10.1089/apb.20.0069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biosafety, erschienen am 01.09.2021. Verfasst von Michael O Baclig. Beteiligte Einrichtung: Research and Biotechnology Group, Center for Basic Science Research, St. Luke's Medical Center, Quezon City, Philippines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research and Biotechnology Group, Center for Basic Science Research, St. Luke's Medical Center, Quezon City, Philippines.
- St. Luke's Medical Center College of Medicine-WHQM, Quezon City, Philippines.
Zitieren
APA
Baclig, M. O. (2021). Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience. Applied Biosafety, 26(S1), S-10-S-15. https://doi.org/10.1089/apb.20.0069
Vancouver
Baclig MO. Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience. Applied Biosafety. 2021;26(S1):S-10-S-15. doi:10.1089/apb.20.0069
BibTeX
@article{Baclig2021,
author = {Baclig, Michael O},
title = {Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience},
journal = {Applied Biosafety},
year = {2021},
volume = {26},
number = {S1},
pages = {S--10--S--15},
doi = {10.1089/apb.20.0069}
}
EUVIMED